Holen Sie sich die Stockscreener-App
25.82
8.53%
2.03
Finanzdaten der Monopar Therapeutics Inc-Aktie (MNPR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
16.22%
0.0822
|
0.0981 | 0.1123 | 0.1282 | 0.0905 |
Operating Expenses
|
9.86%
1.7234
|
1.912 | 2.066 | 2.3282 | 2.525 |
| Benefits Costs and Expenses |
-
|
- | - | - | 2.525 |
| Costs And Expenses |
10.17%
1.8056
|
2.0101 | 2.1783 | 2.4564 | 2.525 |
| Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
| Operating Income/Loss |
9.86%
-1.7234
|
-1.912 | -2.066 | -2.3282 | -2.525 |
| Net Interest Income/Expense |
16.22%
0.0822
|
0.0981 | 0.1123 | 0.1282 | 0.0905 |
| Interest Income/Expense After Provision For Losses |
16.22%
0.0822
|
0.0981 | 0.1123 | 0.1282 | 0.0905 |
| Income/Loss From Continuing Operations Before Tax |
16.22%
0.0822
|
0.0981 | 0.1123 | -2.20 | -2.4346 |
| Income/Loss From Continuing Operations After Tax |
9.52%
-1.6412
|
-1.8139 | -1.9537 | -2.20 | -2.4346 |
|
Net Income/Loss
|
9.52%
-1.6412
|
-1.8139 | -1.9537 | -2.20 | -2.4346 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
5,771%
15.98
|
0.2722 | 14.12 | 13.42 | -0.1563 |
| Basic Earnings Per Share |
16.67%
-0.10
|
-0.12 | -0.14 | -0.16 | -0.19 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):